Matthew Merski1, Cátia Moreira2, Rui Mv Abreu3, Maria João Ramos2, Pedro A Fernandes2, L Miguel Martins4, Pedro José Barbosa Pereira1, Sandra Macedo-Ribeiro1. 1. IBMC - Instituto de Biologia Molecular e Celular and Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal. 2. UCIBIO, REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal. 3. CIMO/ESA, Instituto Politécnico de Bragança, Campus de Santa Apolónia, Apartado 1172, 5301-855 Bragança, Portugal. 4. MRC Toxicology Unit, University of Leicester, Lancaster Road, Leicester, LE1 9HN, UK.
Abstract
HtrA2 (high-temperature requirement 2) is a human mitochondrial protease that has a role in apoptosis and Parkinson's disease. The structure of HtrA2 with an intact catalytic triad was determined, revealing a conformational change in the active site loops, involving mainly the regulatory LD loop, which resulted in burial of the catalytic serine relative to the previously reported structure of the proteolytically inactive mutant. Mutations in the loops surrounding the active site that significantly restricted their mobility, reduced proteolytic activity both in vitro and in cells, suggesting that regulation of HtrA2 activity cannot be explained by a simple transition to an activated conformational state with enhanced active site accessibility. Manipulation of solvent viscosity highlighted an unusual bi-phasic behavior of the enzymatic activity, which together with MD calculations supports the importance of motion in the regulation of the activity of HtrA2. HtrA2 is an unusually thermostable enzyme (TM=97.3 °C), a trait often associated with structural rigidity, not dynamic motion. We suggest that this thermostability functions to provide a stable scaffold for the observed loop motions, allowing them a relatively free conformational search within a rather restricted volume.
HtrA2 (high-temperature requirement 2) is a human mitochondrial protease that has a role in apoptosis and Parkinson's disease. The structure of HtrA2 with an intact catalytic triad was determined, revealing a conformational change in the active site loops, involving mainly the regulatory LD loop, which resulted in burial of the catalytic serine relative to the previously reported structure of the proteolytically inactive mutant. Mutations in the loops surrounding the active site that significantly restricted their mobility, reduced proteolytic activity both in vitro and in cells, suggesting that regulation of HtrA2 activity cannot be explained by a simple transition to an activated conformational state with enhanced active site accessibility. Manipulation of solvent viscosity highlighted an unusual bi-phasic behavior of the enzymatic activity, which together with MD calculations supports the importance of motion in the regulation of the activity of HtrA2. HtrA2 is an unusually thermostable enzyme (TM=97.3 °C), a trait often associated with structural rigidity, not dynamic motion. We suggest that this thermostability functions to provide a stable scaffold for the observed loop motions, allowing them a relatively free conformational search within a rather restricted volume.
HtrA (high-temperature requirement) proteins, named for the inability of deletion
mutants to survive elevated temperatures, are widely distributed throughout nature. They
maintain protein quality in the periplasmic space of Gram-negative bacteria or in the
intermembrane space of the mitochondria in animals and plants.[1, 2, 3] HtrAs are homo-trimeric enzymes, with each subunit composed of a
serine protease domain and one or more regulatory PDZ domains.[1] The protease domain, structurally conserved in this family, has
a chymotrypsin-like fold and several flexible loops – including the surface loops
1-3 (L1-L3), and loops A-D (LA-LD)[4] –
that have critical roles in substrate specificity and allosteric
regulation.[1, 5] Unlike trypsin, which is activated by a proteolytic event that
induces a disorder/order transition,[1]
regulation of HtrA proteases has been linked to (i) ligand binding,[2] typically small hydrophobic peptides to the PDZ
domain,[6, 7,
8] or (ii) increased temperature.[9, 10]The human mitochondrial protease HtrA2 (also known as Omi or PARK13) can be released
into the cytosol,[11] where it cleaves inhibitor
of apoptosis proteins facilitating caspase-dependent apoptosis.[3] In addition, HtrA2 has been associated with several
neurodegenerative disorders.[12, 13] Although multiple structural studies have provided an overall
view of the molecular architecture of human HtrA2,[6,
14] the exact mechanism by which the enzyme is
activated remains unclear. The structure of human HtrA2 catalytic serine mutant S306A,
showed the PDZ packing against the protease domain.[14] Movement of the PDZ domain, facilitated by increased
temperature or by PDZ-binding peptides,[7, 10] was proposed to activate HtrA2, similar to the
allosteric mechanism suggested for the regulation of bacterial DegS.[15] The main structural difference between HtrA2 and
DegS resides in the catalytic site of DegS being continually exposed, whereas the
‘inactive’ resting state is stabilized by interactions at the interface
between the PDZ and the protease domain, which are modified upon enzyme
activation.[15] However, in DegS, the
specific interactions between the activating peptide and the protease domain are
variable and not conserved between different peptides.[16] The variable role played by the PDZ domain in the activation
of the different HtrA proteases suggests that additional features might contribute to
the activation mechanism.[14, 17, 18, 19, 20]Here, the structure of the active form of human HtrA2 protease with a complete catalytic
triad (HtrA2/WT) is reported. The catalytic triad of active HtrA2, which shows
conformational plasticity, is predominantly found in a catalytically incompetent
arrangement. The HtrA2/WT active site is significantly occluded by a LD loop
conformation different from that of the HtrA2/S306A structure.[14] Mutational studies, combined with structural and
molecular dynamics analysis, and the effect of viscosity in HtrA2/WT activity,
suggest that motion in the LD and L1 loops is critical for HtrA2 proteolytic
activity.
Results
Structure of wild-type HtrA2
The structure of the mature form of HtrA2/WT was determined to a resolution of
1.65 Å (Supplementary Information Table
1; Figure 1). The structure is very
similar (Cα RMSD 0.7 Å) to the previously determined
structure of HtrA2/S306A[14]
(Supplementary Information Table 2).
Remarkably, the HtrA2/WT structure revealed a rearrangement of the loops
around the protease active site that buried the catalytic serine. Large
conformational changes are observed within loop LD and active site loop L1
(Figure 1a; Supplementary
Information Figure 1). The main-chain α-carbon of LD loop
residue Q267 is 6 Å closer to active site loop L1, restricting access
to catalytic S306 by shifting F303 (Figures 1b and c).
The PDZ domain of the neighbor subunit is closer to the LD and L1 loops, further
occluding the access to the active site (Supplementary
Information Figure 2A). These changes lead to a partial closure of
the access to the protease catalytic site (Figures 1b and
c). This ‘Buried’ conformation, partially owing to
rearrangements of F303, Q267 and the LD loop, is observed in both HtrA2/WT and
mutant HtrA2 structures (see Supplementary
Information). The LD loop is in direct (<4 Å)
contact with the α1* helix (residues 371*–380* *
indicates an adjacent subunit) of the neighbor PDZ* domain (Figure 2a). There are polar interactions between the PDZ* domain
R380* and D302 in loop L1, and a hydrophobic interaction between L379* and
F303 (Figure 2a). This network of interactions
delineates the communication path from the PDZ regulatory peptide-binding region
(YIGV motif; Supplementary Information Figure 1)
to the active sites across HtrA2 subunits (Figure 2a).
In this ‘Buried’ conformation, a structural rearrangement is
critically required for the peptide substrates to access the protease active site,
involving the coordinated movement of loops L1 and LD and the PDZ domains on
adjacent subunits across the quaternary HtrA2 interface.
Figure 1
Structural rearrangement of active site loops in wild-type HtrA2. (a)
Stereo diagram of the HtrA2/WT monomer in cartoon representation. For
comparison, the loops around the active site whose conformation is changed in the
HtrA2/S306A mutant are superposed (LA=orange, L1=blue,
L2=cyan, L3=pink, LD=red, PDZ domain=salmon, protease
domain=green). Specific residues in HtrA2/WT are labeled and residues
S142, S276 and G399 are shown in space-filling representation; # denotes
residues that shift position in HtrA2/WT. Amino-acid sequence numbering is
based on full-length immature human HtrA2.[14] (b, c) Surface representation of the trimeric
assembly of HtrA2/WT (this work, herein referred to as the
‘Buried’ conformation) and the HtrA2 S306A mutant (PDB entry
1lcy,[14] herein referred to as the
‘Exposed’ conformation). As in panel a the PDZ domain is shown
in salmon, whereas the protease domains are shown in white, pale blue and pale
green to visually differentiate the separate monomeric units
Figure 2
LD and L1 loops interconnect the PDZ domains across adjacent HtrA2 subunits.
(a) The intersubunit interface in HtrA2/WT highlights the key role
of L1 (through D302) in the communication between the catalytic site and both the
LD loop and helix α1 on the PDZ domain of the adjacent subunit (*
indicates residues in a neighbor subunit). The PDZ regulatory peptide-binding
region (YIGV motif) is shown in magenta. (b) A network of polar
interactions centered on the S306 side-chain reorients the active site loops and
partially occludes the access to the protease active site (catalytic triad
residues labeled in red). Dashed lines represent putative hydrogen bonds
cross-linking the L1 and LD loops in panel a), and centered on the active
site S306 in panel b. (c) Free-energy profile along the rotation of
the C-Cα-Cβ-Cγ dihedral of H198 for
the HtrA2/WT (green) and S306A (pink) structures. The rotamers at the two
free-energy minima (−65° and 85°) are shown, with the atoms forming
the dihedral angle highlighted by a black dashed line
Active site remodeling in wild-type HtrA2
The catalytic triad in HtrA2/WT is distorted, with H198 facing away from S306.
The hydroxyl moiety of S306 establishes hydrogen bonds with N196 side-chain and
with T322 main-chain carbonyl (Figure 2b). The third
residue composing the catalytic triad, D228, is shifted away from H198 and forms a
single hydrogen bond with the main-chain nitrogen of A197. Importantly, the K395
side-chain from the PDZ domain establishes a water-mediated interaction with T322,
and stacks between F303 and H198, inducing a concerted movement of the PDZ towards
the HtrA2 active site (Figure 2a; Supplementary Information Figure 2B). The F303 carbonyl shifts by
1.8 Å towards the active site, stabilizing the new loop L1
conformation. The protease oxyanion-binding site is distorted, as often observed
in HtrA enzymes.[21, 22] The catalytic H198 also evidences disorder (Supplementary Information Figure 2B), being observed in
an active rotamer in four of the six HtrA2 structures herein determined (Supplementary Information Figure 2B). Therefore,
restoring the proteolytic triad in HtrA2/WT disrupted the geometry of the
active center and HtrA2/WT was crystallized in a resting state with a
catalytically incompetent conformation.
Molecular dynamics simulations of HtrA2
The conformational plasticity around the HtrA2 catalytic site was further explored
using MD simulations. The modeled structures (WT-S306Amodel and
S306A-A306Smodel) and the two X-ray crystal structures (HtrA2/WT
and HtrA2/S306A) were subjected to MD simulations of 200 ns. In the
simulation with the HtrA2/WT structure, H198 remained in the catalytically
incompetent position (as observed in the wild-type crystal structure) most of the
time, only transiently occupying the active conformation. In agreement with the
experimental data, in the HtrA2/S306A structure the H198 side chain maintained
the catalytically competent conformation observed in the experimental data during
the whole simulation. In the WT-S306Amodel system the H198 side-chain
changed from the catalytically incompetent to the active rotamer during the
200 ns of simulation or, in the case of chain A, during energy minimization
before the 200 ns MD simulation, and maintained that conformation during
the entire simulation. In the S306A-A306Smodel simulation, the
conformation of the catalytic triad was kept mainly in a catalytically competent
conformation. However, during the simulation, the side-chain of H198 moved away
from S306, together with the catalytic D228, although it did not complete the full
shift to the conformation observed in the crystal structure of HtrA2/WT. In
summary, the presence of a serine residue in position 306 favors an inactive
conformation of H198, thereby perturbing the geometry of the active site.To provide quantitative details on the conformational plasticity of the HtrA2
active site, the free-energy profile for the rotation of the H198 side chain along
the
C-C-C-C
dihedral was calculated with umbrella sampling MD, in both the WT and the S306A
structures. The free-energy profile (Figure 2c) shows
two stable dihedral angles (circa 85° and −65°),
corresponding to the values seen in the two experimental structures. The more
stable dihedral in the HtrA2/WT X-ray structure has a value of 85°,
explaining the prevalence of such ‘inactive’ conformers in the crystal
structure (detailed description in Supplementary
Information).
Molecular dynamics simulations of conformational changes around the active
site of HtrA2
Major conformational changes were observed between the crystal structures of
HtrA2/WT and HtrA2/S306A, in loop LD and for F303, accompanied by a motion
of the PDZ domain toward the catalytic site. No major changes were observed in the
simulations that started from the HtrA2/WT structure, as expected, as the
transition of loop LD from the ‘Buried’ (HtrA2/WT) to the
‘Exposed’ (HtrA2/S306A) conformation would result in a clash
between Q267 and residues in PDZ*. The LD loop shifted to a position similar
to the one found in the HtrA2/WT X-ray structure (‘Buried’
conformation) in both simulations that started from structures with the S306A
mutation (HtrA2/S306A crystal structure and S306A-A306Smodel), with
residue F303 consistently moving between the ‘Exposed’ and
‘Buried’ conformations. This result suggests that the loop is free to
sample both conformations and that over a much longer timescale the movement of
the loop LD back and forth between the two conformations may be observed.The position of the PDZ domain relative to the protease domain also changed in the
HtrA2/WT structure. In fact, reorganization of the catalytic triad geometry is
related to a motion of the PDZ domain towards the protease domain, centered on the
water-mediated interaction between the K395 side chain and the T322 carbonyl. To
investigate the role played by this movement of the PDZ domain on the
conformational changes of loop LD, two additional models were built, by direct
replacement of the PDZ domains (WT-PDZS306Amodel and
S306A-PDZWTmodel). Both models were subjected to
200 ns MD simulations. The results strongly suggested that the PDZ domain
indeed influences the position of both the LD loop and the F303 side chain. In the
WT-PDZS306Amodel a spontaneous and gradual transformation
of the LD loop conformation from the ‘Buried’ to the
‘Exposed’ conformation was observed, while in the simulations of the
S306A-PDZWT
model, the LD loop gradually and spontaneously changed to a
conformation resembling the one in the HtrA2/WT crystal structure with F303
occluding the active site, demonstrating the high flexibility of these
conformations.
Engineering ‘Exposed’ and ‘Buried’ HtrA2
conformations
To analyze the effect of active site exposure on the proteolytic activity of
HtrA2, mutations were introduced to favor either the ‘Exposed’
conformation of the LD loop observed in S306A (Figure
1c) or the ‘Buried’ conformation observed in the WT
structure (Figure 1b). In brief, the HtrA2/Open
construct contained the mutation L266R to create hydrogen bonds with helix
α1* of the neighboring PDZ domain, as well as the space-making F303A
mutation, whereas the HtrA2/Closed construct introduced N181S and mutations
Q267R, N268A, T269E to create hydrogen-bonding interactions to favor the
‘Buried’ LD loop conformation. These efforts were greatly aided by the
inherent stability of HtrA2, which melts above 95 °C (Supplementary Information Figures 3 and 4), an unusually
high temperature for a cytosolic human protein.[23] The structure of the active conformation-favoring
HtrA2/Open mutant was determined at 1.69 Å resolution (Supplementary Information Table 1). The LD loop and
catalytic triad are in the same basic conformation in both the wild-type and the
HtrA2/Open structures. In HtrA2/Open the space-making F303A mutation
increases the exposure of the active site S306 residue (Supplementary Information Figures 2A). MD simulations of the
HtrA2/Open construct suggest that R266 is highly mobile, but the L1 and LD
loop conformations were unchanged during the 200 ns MD simulation
(Supplementary Information movie 1). MD
simulations also showed that, in the absence of the aromatic side chain of F303,
Q267 shifted toward loop L1, restricting its mobility and enhancing active site
accessibility (Supplementary Information Figure
5A).The HtrA2/closed construct could not be crystallized, but the mutations
(N181S, Q267R, N268A, T269E) were modeled and MD calculations were carried out to
explore the dynamics of the loops surrounding the active site. The modeling and MD
simulations of the HtrA2/Closed structure suggest the establishment of a
strong interaction between S181 and R267 (Supplementary
Information Figure 5B). Another strong contact is established by
mutation T269E, that interacts with R380* of the α1* helix from the
neighboring PDZ domain. These interactions affect the mobility of the LD loop,
which remained locked in its initial position for the whole simulation, whereas
the active site remained mostly buried (Supplementary
Information Figure 5B, Supplementary
Information movie 2).Both sets of mutations that were originally designed to favor specific
conformational states either exposing or hindering the catalytic site were highly
detrimental to the protease activity of HtrA2, reducing it by 2000- and
15 000 fold for the HtrA2/Closed and HtrA2/Open mutants,
respectively (Supplementary Information Table 3).
This loss of activity was also mirrored by a significant reduction in the ability
of these mutants to induce cell death when transiently transfected into U2OS cells
(Figure 3). In every case – including S306A
– the catalytic serine would be considered buried by
convention,[24] but the substrate
was still able to enter the active site and be hydrolyzed in HtrA2/WT,
although curiously less efficiently in mutants that have more open active sites
(Supplementary Information Table 3). Taken
together, these results suggest that simply favoring a more exposed conformation
of the catalytic triad does not lead to increased HtrA2 enzymatic activity. MD
simulations with HtrA2/WT and the two designed constructs suggested that the
engineered mutations in both HtrA2/Open and HtrA2/Closed decrease the
mobility of the loops surrounding the enzyme active site (Supplementary Information Figure 5; Supplementary Information movies 1-3).
Figure 3
Mutations in the LD loop prevent HtrA2-induced cell death. (a) Mutations
that favor either the exposure or burial of the catalytic site (Figure 1) greatly reduce cell death upon HtrA2 expression in U2OS
cells. Each data point represents a separate biological replicate while bar height
represents the mean value of all three measurements. (b) Representative
micrographs showing U2OS cells dually expressing HtrA2 and GFP (green), both
viable and dead (indicated by DRAQ7 staining, red). Expression of HtrA2/WT in
the cytoplasm (top right) visibly induces (correlation of green GFP expression and
red cell death indicator DRAQ7) much more cell death than when HtrA2/Open,
containing LD mutations, is expressed (bottom right)
A search of the PDB for other HtrA enzymes with a protease domain and at least one
PDZ found 26 additional structures (see Supplementary
Information). All the structures were aligned by the PDZ domain and
pairwise comparisons of the distances between the Cα atoms of the
catalytic serine were made and then clustered into at least five groups (Figure 4). The lack of an obvious factor that gave rise to
the groups suggests the conformations are largely stochastic (animated as
Supplementary Information movie 4).
Figure 4
Relationship between the relative orientations of PDZ domains in HtrAs organized
by complete linkage hierarchical clustering. (a) Tree plot showing the
relationship between the PDZ domain orientation and the protease active site in
HtrA proteins in the PDB, which appear to fall into at least five groups. The
grouping was generated by hierarchical clustering using complete linkage of the
pairwise distances between the Cα carbon of the catalytic serine residues.
Structures were grouped at an arbitrary cutoff of 20 Å (red line).
(b) Heatmap representation of the pairwise spatial distance between the
catalytic residues of HtrA protein structures in the PDB when the PDZ domains are
superposed. PDB entry code is given for each group member inside parentheses. The
names used for HtrA2 structures from this report are also given where appropriate.
The five groupings are also clearly visible from this representation as similar
(warm, red) relationships can be readily distinguished from further (cool, blue)
ones in the heatmap
The effect of viscosity on HtrA2 activity
To assess the role of dynamic motion in HtrA2 proteolytic activity, the enzymatic
activity of HtrA2 was measured at different solution viscosities. Increasing
solution viscosity by addition of the microviscogen glycerol increased both
HtrA2/WT and HtrA2 ΔPDZ activity (Figure
5a).[25] This observation
is in contrast to the traditionally observed activity decrease at high viscosity
for enzymes that have a viscosity dependence.[25] The mean
k/K value is
12-fold greater at a moderate relative viscosity
η=2.4–3.5 for HtrA2/WT, whereas the mean activity
increase for ΔPDZ HtrA2 achieved a maximum of ninefold increase at
η=2.4. A 1:1 correlation between relative viscosity
(η) and relative activity is typically considered good evidence
for viscosity dependence in enzyme activity,[25] a value that both HtrA2/WT and ΔPDZ mutant exceed
at moderate viscosities (Figure 5). Increasing the
solution viscosity beyond moderate values resulted in reductions in
k/K from
the observed maxima, more in line with traditionally expected
behavior.[25] Similar results were
also observed for the HtrA2 mutants (Supplementary
Information Figure 6). In the presence of a larger viscogen, PEG
8000, the proteolytic activity of HtrA2/WT and HtrA2 ΔPDZ decreased with
increasing solution viscosity, which is also indicative of the role of dynamic
motion in catalytic activity (Figure 5b). Notably,
both chemically different viscogens reduce HtrA2 proteolytic activity at high
viscosities (η>3.5), as expected for enzymes in which protein
conformational change plays a role in activity.[25, 26]
Figure 5
Effect of viscosity on HtrA2 proteolytic activity. For clarity this graph shows
the ratio of
(k/K)/
(k/K)0,
which better indicates increased enzymatic activity than the standard
(k/K)0/(k/K)
that best represents suppressive viscosity effects, thus leading to an inverse fit
line. The dashed line indicates the traditionally expected 1:1 antagonistic
relationship between viscosity and enzyme activity.[63] The solid blue line at
(k/K)/
(k/K)0=1
is the expected result if there is no correlation between enzyme activity and
solution viscosity. (a) The effect of the microviscogen, glycerol, on HtrA2
proteolytic activity in 50 mM phosphate pH 8.0, 150 mM KCl. Note the
offset axis as the effect of viscosity on HtrA2 activity is quite significant.
Each data point represents the mean value of a separate experiment. (b)
Representation of the effect of the viscogen, PEG 8000, on HtrA2 proteolytic
activity in 50 mM phosphate pH 8.0, 150 mM KCl. Each data point is
the mean value of a measurement performed in triplicate
Discussion
Although there are numerous reports of observed transitions in HtrA enzymes between
‘active’ and ‘inactive’ states,[1, 8, 9,
27] a simple two-state model cannot account
for the observed behavior of HtrA2. Counter to expectations, the crystal structures
and MD simulations of HtrA2 both demonstrate a preference for greater steric
occlusion of the active site in the WT enzyme compared with the S306A inactive
mutant. Mutations designed to stabilize a single conformation of the LD loop led to
significant losses in activity (Supplementary Information Table
3), suggesting that locking HtrA2 into a single conformational state is
not conducive to its function, a property that has been noted in other HtrA
proteins[16, 20] and other proteases.[26] Although there is a generally accepted active arrangement for
the catalytic triad of serine proteases, analysis of the orientations of the PDZ
domain with respect to the protease domain reveal at least five conformations
(Figure 4). No PDZ orientation could be definitively
correlated with the ‘active’ conformation in DegP,[28] nor was there any obvious conservation of
contacts with the protein in the structures of a set of 14 DegS ligands.[16] The large number of orientations observed
between these two domains in structures of HtrA proteases, as well as the lack of any
over-arching causative factor that would favor any given orientation suggests a
significant degree of stochasticity in these conformations. In addition, increased
solution viscosity significantly modified proteolytic activity in HtrA2/WT and
mutants, indicating that normal HtrA2 activity includes a significant protein motion
component, as confirmed by MD simulations of HtrA2 (Supplementary Information Figure 5 and Supplementary Information movies 1-3).
HtrA structures generally require rearrangements to achieve optimally active
conformations
The catalytic triad in the HtrA2/WT structure is disrupted, with the nearest
accessible H198 side chain atom positioned 5.9 Å away from the
carboxylate oxygen of D228 and separated from the hydroxyl of S306 by
7.4 Å, requiring substantial rearrangements to re-establish a
catalytically competent conformation (Supplementary
Information Figure 2). Distorted geometries of the catalytic triad
resulting from unusual rotamer conformations of the active site histidine side
chain have also been observed in Escherichia coli DegS[15] and human HtrA1.[29] Structures of DegS with activating peptides have failed
to demonstrate a consensus set of activating interactions between the peptide and
the protease domain, suggesting that activation does not occur by locking in a
specific active conformation.[16] The
paralogous human protein, HtrA1, is also known to be conformationally flexible in
solution: six reported HtrA1 monomers display different active site
conformations,[29] and their PDZ
domains are disordered in crystal structures of the mature protease.[30] These observations point to the role that
dynamics have in HtrA2 function, as noted previously.[5, 10, 21, 31, 32]
Large-scale, stochastic protein rearrangements occur in HtrA
proteins
Although only small changes are observed in the relative positions of the HtrA2
protease and PDZ domains, the HtrA family as a whole undergoes massive
(>100 Å) orientational changes (Figure
4; Supplementary Information movie 4).
Although the number of possible causes for these changes relative to the number of
structures available (n=32) precluded a truly stringent
statistical analysis, the lack of obvious causes and the considerable space
sampled by these movements suggests that these large-scale rearrangements are
largely stochastic, comparable to the small-scale active site movements of
proteins in solution, which are observed in the MD simulations of HtrA2 and in a
report of gradual relaxation and expansion coupled with a complex set of changes
in HtrA2 with increasing temperature.[10]
Direct evidence for motion in HtrA2
Upon observing conformational changes in the LD loop (F264-S272) and F303 on loop
L1 in the crystal structures of HtrA2, a two-state transition between an
enzymatically active state and an inactive (resting) state was initially assumed,
as has been previously proposed for other HtrA enzymes.[9, 15, 27] However, this interpretation raised several issues.
First, the active site residue S306 is more solvent exposed in the inactive
HtrA2/Open mutant than in the active HtrA2/WT (Figure
1,Supplementary Information Figure
2C). Second, LD loop mutations that decrease the proteolytic activity
in HtrA2/Open and HtrA2/Closed significantly constrain the dynamics of the
loops surrounding the active site, as observed in MD simulations (Supplementary Information movies 1-3). Mutations in the
LD loop also drastically reduce protease activity in DegS[33] and have been recently shown to modulate human HtrA2
activity.[6] In addition, the
expected primary importance of a specific ‘active’ conformation is in
contrast to the often-reported increase in activity of the protease at higher
temperatures, where conformational flexibility is expected to
increase.[9, 10] It could be argued that the increased flexibility allows
easier barrier crossing into the active conformation, but the observation of these
conformations in both liganded and unliganded structures (Supplementary Information Table 4) suggests otherwise. Third, the
proteolytic activity of HtrA2 is clearly affected by changes in solution viscosity
(Figure 4), both by the small molecule glycerol
(RH=3.1 Å)[34] and the much larger PEG 8000
(RH=27.5 Å),[35] suggesting a dependence on dynamic motion for
proteolytic activity.[25, 36] It is unlikely that this dependence is due to binding of
glycerol as an allosteric ligand, as there was no clear evidence of glycerol in
any of the six experimental structures here reported despite its inclusion in the
crystallization solutions. As the effect of solvent viscosity on protease activity
is bimodal, changing from activity increasing at moderate viscosities to more
traditional activity inhibition at high viscosities (Figure
5), it is unlikely to result from bulk solvent effects such as protein
hydration. Furthermore the much larger, chemically different molecule, PEG 8000,
also affects activity. Interestingly, the bimodal dependence on viscosity suggests
that there are both classical activity-enhancing[25] and activity-suppressing motions that are functionally
important in HtrA2. Although activity-suppressing effects in HtrA proteins have
been linked to the PDZ domain,[8, 14] activity-enhancing effects have traditionally
been attributed to the protein achieving a catalytically optimal conformational
state[9] or increases in temperature
(e.g., increased molecular motion).[9, 10] All these observations are consistent with
dynamic protein motions and, in fact, cannot be accounted for entirely by the
invocation of a simple activated ‘state’ of HtrA2. We suggest that,
much like the movements of a grandfather-style clock, dynamic protein motions are
important to HtrA protease activity. Although snapshots (crystal structures) may
find certain conformations, the position of the pendulum can only partially
explain the function of the clock. Overall, these results illustrate the essential
role of dynamic motions in HtrA2 activity, a feature that is likely shared by
other HtrAs.
Materials and methods
All reagents used were commonly commercially available except where otherwise
noted.
Cloning and protein expression
HtrA2/WT (Addgene plasmid #14126, Cambridge, MA, USA), as well as the
A141S (Addgene plasmid #16157), S142D (Addgene plasmid #16154), G399S
(Addgene plasmid #16158) and S276C point mutants were purified as
described.[7] Further mutations to
the HtrA2 gene were introduced using the method of overlap extension[37] and ligated into the pET-29 expression vector
(Novagen, Darmstadt, Germany) using introduced restriction sites NdeI and
XhoI. Cloning into pET-29 resulted in the insertion of two extra
residues (leucine and glutamate) into the HtrA2/WT, HtrA2/Open,
HtrA2/Closed and HtrA2 ΔPDZ constructs used for activity and
thermostability experiments, which were not present in the crystal structure of
HtrA2/WT. The additional residues did not appear to change the quaternary
structure of HtrA2 as assessed by native PAGE. Amino-acid sequences for the
proteins used in this work are given in Supplementary
Information Table 5. Plasmids containing HtrA2 variants were
transformed into E. coli BL21 (DE3) cells and grown at 37 °C
with shaking in LB medium containing kanamycin until an
O.D.600=0.5–0.7 was reached. The cultures were then
quickly cooled on ice, induced with 1 mM isopropyl
β-d-1-thiogalactopyranoside and grown overnight at
16 °C. Cells were then harvested by centrifugation, frozen in liquid
nitrogen and stored at −80 °C until used. Cell pellets were
resuspended in 125 ml of lysis buffer (10 mM imidazole pH 7.0,
300 mM NaCl, 1% (v/v) Triton X-100) per liter of culture and
lysed by sonication on ice. Protease inhibitors were not used during protein
purification. The lysate was clarified by centrifugation at 15 000 ×
g for 40 min and applied to a HisTrap FF column (GE Healthcare,
Life Sciences, Freiburg, Germany). The column was washed with 10–20 column
volumes of 30 mM imidazole pH 7.0, 300 mM NaCl, 20% (v/v)
glycerol, and the bound proteins eluted with 250 mM imidazole pH 7.0,
150 mM NaCl, 20% (v/v) glycerol. The eluted protein was
concentrated with a centrifugal ultrafiltration device (Millipore, Darmstadt,
Germany; 10 kDa cutoff) and then applied to a Sephacryl S-300 column (GE
Healthcare) pre-equilibrated in HtrA2 storage buffer (50 mM Tris pH 8.0,
150 mM NaCl, 20% (v/v) glycerol). Fractions containing HtrA2
were pooled, concentrated as described above, frozen in liquid nitrogen, and
stored at −80 °C. Protein concentrations were determined using a
Direct Detect infrared spectrometer (Millipore).
Crystallization and structure determination
Crystals were grown using the sitting drop vapor-diffusion method by mixing equal
volumes of protein (10–15 mg/ml) and reservoir solution (0.1 M
MES pH 6.0, 1 M LiCl, 15–20% (w/v) PEG 6000). Crystals grew to a
typical size of 0.4 × 0.4 × 0.5 mm3 within 4–5
days at 20 °C. The crystals, belonging to space group H3 and containing
one molecule in the asymmetric unit, were cryoprotected by equilibration in
crystallization buffer supplemented with 25 % (v/v) glycerol and flash
frozen in liquid nitrogen. Diffraction data (each set from a single crystal) were
collected at ESRF (Grenoble, France) beamlines ID14EH3 and ID29[38] and were processed with MOSFLM[39] (WT, and A141S, S142D, S276C and G399S
mutants) or XDS[40] (HtrA2/Open) and
scaled with SCALA.[41] The structures were
solved by molecular replacement using the coordinates of HtrA2/S306A (PDB
entry 1lcy[14]) as search model, refined
with PHENIX using TLS,[42, 43] and rebuilt manually using COOT.[44] Crystals obtained for HtrA2/WT and
mutants A141S, S142D, S276C, and G399S were significantly twinned and refined
using the twin law h, -h-k, -l. Structures were checked for errors using
MolProbity.[45] Figures were
prepared with PyMOL (Schrödinger). There were notable gaps in the electron
density for the N- and C-termini, within the L3 loop (between residues R280-V292
with small variations in the different structures), and for the linker region
between the protease and PDZ domains (G345-S357) common for all the structures
described in this work (Figure 1 and Supplementary Information). For the structures here
determined, all residues were in favored/allowed regions of the Ramachandran
plot. The refined coordinates and corresponding structure factors were deposited
at the Protein Data Bank with accession codes 5m3n (wild-type), 5m3o (A141S
mutant), 5tnz (S142D mutant), 5tny (G399S mutant), 5to0 (S276C mutant), and 5to1
(Open mutant).
HtrA2 functional assays
HtrA2 activity was measured using an artificial fluorescent peptide substrate
(H2-Opt) in a Molecular Devices Spectramax Gemini XS fluorescence plate reader
with temperature control (λexcite=320 nm,
λemit=395 nm).[7] The substrate (dissolved in DMSO) was diluted to assay
concentrations of 7–26 μM in assay buffer (100 mM
buffer, 400 mM KCl, 20% (v/v) glycerol) for the pH variation
experiments. The concentration of DMSO never exceeded 1% (v/v) in the
assay. All reaction components (including HtrA2) were mixed and allowed to stand
for 10 min at the appropriate temperature before the reaction was started
by addition of the fluorogenic substrate.[7] The buffers used for the pH variation experiment were
acetate (pH 5.0 and 5.7) and phosphate (pH 5.7–8.3). Controls lacking HtrA2
were used to establish an endogenous rate of hydrolysis and this was subtracted
from the total rate observed in the presence of enzyme. Due to limits in substrate
solubility and the low binding affinity of the peptide substrate, analysis was
limited to the
k/K ratio.
The mean k/K
values reported for a given temperature for HtrA2/WT were determined from the
mean values for that temperature over a pH range of 6.7–8.3. The
k/K values
reported for mutant HtrA enzymes are the mean value of a set of measurements
performed in triplicate at 37 °C.Viscosity measurements were performed in 50 mM Tris pH 8.0, 150 mM
NaCl with varying concentrations of viscogen (0–80 % (v/v)
glycerol or 0–30 % (w/v) PEG 8000) as above. Buffer viscosities
were determined using a Myr Rotational viscometer V2–V3000 at room
temperature (19–23 °C) and normalized to the viscogen-free
control.[25, 46] The glycerol viscosity experiments for HtrA2/WT and
HtrA2 ΔPDZ are the mean values of three separate experiments performed in
triplicate. For the viscosity experiments, each graphical data point represents
the mean value of a separate experiment (n=3 for WT &
ΔPDZ with glycerol and n=1 for all others).
Molecular dynamics simulations
The HtrA2/WT and S306A mutant (PDB entry 1lcy[14]) crystallographic structures served as base for building
models to explore the conformational differences between these two structures.
Eight models were built, all as homotrimers containing chains A, B and C, with
each chain being formed by residues S142-Q279, E293-H343 and R359-E458. Of these
eight models, two (HtrA2/WT and S306A) were experimental X-ray structures. To
analyze the influence of the S306 hydroxyl moiety on the geometry of the catalytic
triad two models were prepared: WT-S306Amodel (S306A mutation was
modeled in the HtrA2/WT crystal structure) and S306A-A306Smodel
(A306S mutation was modeled back in the crystallographic structure originally
carrying the S306A mutation). Two models resulted from the introduction of the
mutations that specifically favor the exposure or burial of the active site. These
correspond to L266R and F303A, in the HtrA2/Open model, and N181S, Q267R,
N268A and T269E, in the HtrA2/Closed model. The last two models resulted from
the substitution of the PDZ domain, by superposing the protease domains and
changing the PDZ domains from the wild-type structure to the S306A structure
(WT-PDZS306Amodel) and vice-versa
(S306A-PDZWTmodel). In the HtrA2/WT X-ray structure the
PDZ domain is more distant from the protease domain, whereas in the S306A crystal
structure the PDZ domain is significantly closer to the protease domain.The protonation states of the residues were checked with the
H++[47] and
PROPKA[48] webservers, and visually
confirmed afterwards, with all residues falling under the standard protonation
states except residues H170, H389, H403 (which were modeled as positively charged)
and E376 (which was modeled as neutral). The Leap extension of the Amber 12
package[49] was employed to add all
hydrogen atoms, TIP3P water molecules (~30 000 water molecules) and counter
ions (3 Na+) to generate neutral systems, inserted in octagonal
water boxes of 15 Å. The FF12SB force field[50, 51, 52] was employed to describe the protein. Energy
minimizations were performed with the Sander module following a four-stage
protocol. Harmonic potentials (50 kcal/mol/Å2
force constant) were used at first to restrain the positions of selected atoms in
the systems, and later removed: stage 1 (500 steps) all atoms except those from
the water molecules were restrained; stage 2 (800 steps) the restraints on the
hydrogen atoms were released; stage 3 (2500 steps) only the backbone chain atoms
were restrained; and stage 4 (6000 steps) all the system was free. After fully
optimizing the system, a MD of 20 ps was performed with the temperature
being raised from 0 to 300 K at constant volume, followed by simulations of
200 ns (see below) at constant temperature and pressure (at 300K and 1bar,
controlled by Langevin thermostat[53] and
Berendsen barostat[54]). The time step
used was 2 fs. The SHAKE algorithm was used to fix the bond length between
hydrogen atoms and heavy atoms. The PMEMD (Particle Mesh Ewald Molecular Dynamics)
module was employed in these calculations, with a cutoff of 10 Å for
both the short- and the long-range interactions. The information collected from
the 200 ns MD simulations was analyzed with the CCPTRAJ module of AMBER 12
and visualized with the VMD software.
Umbrella sampling calculations
The two X-ray structures (HtrA2/WT and S306A mutant) were submitted to
umbrella sampling MD calculations in order to build up a free-energy profile for
the rotation of the H198
C-C-C-C
dihedral. The geometry-optimized structure was the starting point for the
calculations. The temperature of the system was raised from 0K to 300K in a
20 ps MD simulation (with similar conditions as those previously described,
except that the H198
C-C-C-C
dihedral was fixed) with a 1 fs time step. The dihedral angle in the study
was initially fixed at 60° and then subsequently increased/decreased in
5° steps, until the complete rotation (360°) was explored (72 simulation
windows). The starting points in each window were generated by a series of
sequential short (100 ps) simulations with a
0.12184 kcal/mol/deg2 harmonic force constant applied
to the dihedral angle. The 72 dihedral windows were then sampled for 10 ns,
and analyzed by the weighted histogram analysis method[55] to obtain the free-energy profiles. The umbrella
sampling MD was performed with the PMEMD module, with the previously described
conditions for normal MDs. The uncertainty of free-energy profiles is not easy to
estimate, as it has both a statistical source (easy to calculate, here below
0.3 kcal/mol) and a source that comes from the inaccuracy of the force
field parameters, which is quite difficult to quantify. In most cases where direct
comparison with accurate experiments is possible, the errors in the computational
free energies in several different contexts lie
~1.1–1.5 kcal/mol, or around one order of magnitude in
equilibrium/rate constants.[56, 57, 58, 59]
Cell-based apoptosis assay of HtrA2
U2OS cells were plated in 24-well plates at a concentration of 3 ×
104 cells/well in MEM medium (Gibco, Waltham, MA, USA) with 0.5
% antibiotic antimycotic solution (SIGMA, St. Louis, MO, USA) at
37 °C and allowed to attach overnight. Cells were transfected using
Lipofectamine 3000 (Invitrogen, Waltham, MA, USA) with 1 μg of
pIRES2-EGFP containing the HtrA2 gene. After 6 h the medium was exchanged
and cells were allowed to continue growing at 37 °C. Two days after
transfection cells were stained with DRAQ7 and imaged with an IN Cell analyzer
2000 (GE Healthcare). The fraction of dead (as indicated by DRAQ7 staining)
GFP-positive cells was calculated for each well. At least 150 GFP-positive cells
were counted in each well. Results from each of three separate biological
replicate experiments are plotted individually on Figure
3.
Comparison of HtrA trypsin-like and PDZ domain relative positions
HtrA structures were downloaded from the Protein Data Bank (www.rcsb.org) and aligned using
specifically their PDZ domains with PyMOL to the HtrA2 S306A
structure.[14] If the protein
contained multiple PDZ domains, the most N-terminal one was utilized. All against
all pairwise comparisons were made by measuring the distance between the Cα
carbon atoms of the protease active site serine (or alanine) residue. The data
were organized using hierarchical clustering with complete linkage using
MultiDendrograms 5.0.[60] Heat maps were
generated with R[61] using the heatmap.2
function of the gplots package.[62]
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Authors: Oksana Gerlits; David A Keen; Matthew P Blakeley; John M Louis; Irene T Weber; Andrey Kovalevsky Journal: J Med Chem Date: 2017-02-28 Impact factor: 7.446
Authors: T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie Journal: Acta Crystallogr D Biol Crystallogr Date: 2011-03-18
Authors: Yuki Toyama; Robert W Harkness; Tim Y T Lee; Jason T Maynes; Lewis E Kay Journal: Proc Natl Acad Sci U S A Date: 2021-03-16 Impact factor: 12.779
Authors: Alexander I Denesyuk; Mark S Johnson; Outi M H Salo-Ahen; Vladimir N Uversky; Konstantin Denessiouk Journal: Int J Biol Macromol Date: 2020-03-06 Impact factor: 8.025